Loading page...
Loading page...
Forbion III Management BV · Multi-Country
Forbion Capital Fund III is a 2015-vintage life sciences venture fund managed by Forbion, headquartered in Naarden, Netherlands. It invests in innovative biotech and pharmaceutical companies across all stages of drug development in Europe and North America, with holdings including Dyne Therapeutics and EnGene.
Choose your AI and follow the walkthrough. Your free EUACC account connects the two.
Illustrated walkthrough
https://www.euacc.ai/api/mcpWorks on every Claude plan, including Free (one custom connector). On Team and Enterprise, an Owner adds it.
On a phone, add it at claude.ai in your browser. It then shows up in the Claude app the next time you sign in.
Use EUACC to explore “Forbion capital fund iii c v” (https://www.euacc.ai/investors/forbion-capital-fund-iii-c-v). Help me assess investor fit and prepare questions using the available fund profiles. Cite the available sources and flag missing or outdated information.